Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05076266 · ClinicalTrials.gov registry record
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
A clinical trial, sponsored by Eastern Cooperative Oncology Group.
- Terminated
- Registry status
- 14
- Enrollment target
NCT05076266: Clinical Trial study, sponsored by Eastern Cooperative Oncology Group.
NCT05076266 is a clinical trial that was terminated before completion, run by Eastern Cooperative Oncology Group. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05076266 was terminated before completion, sponsored by Eastern Cooperative Oncology Group.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether factors that lead Women of Color to decline participation in the breast cancer screening trial EA1151 (TMIST) differ from non-women of color.
Primary Outcome
Composite outcome, defined as the logistic modeling of personal changes due to COVID: including layoff or furlough, insurance loss, work hours reduction, new job/increased hours to increase income, food or housing insecurity OR household changes due to COVID: greater or equal to 20% income lose, savings use for living expenses, home sale/refinance, increased debt, declared bankruptcy
Interventions
- OTHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2023-02-03 |
Why NCT05076266 stopped before completion
NCT05076266 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT05076266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05076266 about?
NCT05076266 is a clinical study titled "COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation". The purpose of this study is to find out whether factors that lead Women of Color to decline participation in the breast cancer screening trial EA1151 (TMIST) differ from non-women of color.
What is the current status of trial NCT05076266?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2022-03-14. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT05076266?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT05076266?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy